Photo of Mark Lewis from netrf.org
Jun 7, 2024, 12:08
Mark Lewis: Median OS for SCLC approach the conventional 5-year milestone
Mark Lewis shared on X/Twitter:
”Not every day that you get to celebrate a years-long survival advantage in the treatment of small cell lung cancer!!!
Mind-blowing to see the median overall survival for limited stage SCLC approach the oncologically conventional 5-year milestone.”
Source: Mark Lewis/X
Mark Lewis is the Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, the Co-Chair of adolescent & young adult (AYA) oncology in the SWOG cooperative group, and the Vice President of American Multiple Endocrine Neoplasia Support. Dr. Lewis is also a well-known patient advocate and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 08:59
Nov 13, 2024, 08:39